Inventor · disambiguated record
Bryan Roth
Also filed as: ROTH BRYAN · ROTH BRYAN L · ROTH BRYAN LEO
14 granted patents·7 pending applications·86 citations·filing 1999–2025
90Inventor score
Files withUNIV CALIFORNIA5UNIV NORTH CAROLINA CHAPEL HILL3UNIV VIRGINIA COMMONWEALTH3KOZIKOWSKI ALAN2UNIV DUKE2
Top patents by PatentIndex Score
21 records- 0188US6518297B2Selective 5-HT6 receptor ligandsUNIV VIRGINIA COMMONWEALTH·Filed 2002·Granted Feb 11, 2003·20 cites·2 claims
- 0287US6403808B1Selective 5-HT6 receptor ligandsUNIV VIRGINIA COMMONWEALTH·Filed 1999·Granted Jun 11, 2002·35 cites·6 claims
- 0386US10702498B2MU opioid receptor modulatorsUNIV CALIFORNIA·Filed 2016·Granted Jul 7, 2020·4 cites·28 claims
- 0485US11484525B2Mu opioid receptor modulatorsUNIV CALIFORNIA·Filed 2020·Granted Nov 1, 2022·1 cites·18 claims
- 0585US6489488B2Selective 5-HT6 receptor ligandsUNIV VIRGINIA COMMONWEALTH·Filed 2002·Granted Dec 3, 2002·17 cites·2 claims
- 0677US10301630B2Methods and compositions for unsilencing imprinted genesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Granted May 28, 2019·1 cites·6 claims
- 0774US9714427B2Methods and compositions for unsilencing imprinted genesPHILPOT BENJAMIN DAVID·Filed 2011·Granted Jul 25, 2017·3 cites·5 claims
- 0873US9156822B2Functionally selective ligands of dopamine D2 receptorsJIN JIAN·Filed 2011·Granted Oct 13, 2015·2 cites·11 claims
- 0972US8754132B2Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptorUNIV ILLINOIS·Filed 2013·Granted Jun 17, 2014·2 cites·7 claims
- 1065US8492591B2Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptorKOZIKOWSKI ALAN·Filed 2011·Granted Jul 23, 2013·1 cites·10 claims
- 1164US2025298017A1G protein-coupled receptor screening systemsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2025·Application pending·0 cites
- 1263US2022117967A1Compositions and Methods for the Treatment of Prader-Willi SyndromeUNIV DUKE·Filed 2021·Application pending·0 cites
- 1358US11278550B2Compositions and methods for the treatment of Prader-Willi syndromeUNIV DUKE·Filed 2017·Granted Mar 22, 2022·0 cites·16 claims
- 1455US2024366606A1Mrgprx2 antagonists and uses thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1553US12360111B2G protein-coupled receptor screening systemsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Granted Jul 15, 2025·0 cites·17 claims
- 1652US2023365542A1Selective Agonists of 5-HT2A Receptor and Methods of UseUNIV YALE·Filed 2021·Application pending·0 cites
- 1751US2023052740A1Modulators of circadian rhythms and uses thereofUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1847US7687538B2Agents with selective κ-opioid receptor affinityUNIV MISSISSIPPI·Filed 2005·Granted Mar 30, 2010·0 cites·21 claims
- 1944US2020109126A1Mu opioid receptor modulatorsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 2040US2009203750A15-HT2C Receptor Agonists as Anorectic AgentsKOZIKOWSKI ALAN·Filed 2006·Application pending·0 cites
- 2137US11613547B2G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitmentUNIV OF HEALTH SCIENCES & PHARMACY IN ST LOUIS·Filed 2020·Granted Mar 28, 2023·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Bryan Roth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →